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Water extracts of skin contain two factors that inhibit epidermal cell proliferation: one 
substance inhibits epidermal cells in the G. phase (the epidermal G. inhibitor), and another 
inhibits the transit of cells from the G, phase into the S phase (the epidermal G, inhibitor). 
Pretreatment of mice with a beta-receptor antagonist (propranolol) abolished the activity of 
the G. inhibitor but not that of the G, inhibitor. After pretreatment with both propranolol 
and a phosphodiesterase inhibitor (caffeine) the G, inhibitor had full effect. Caffeine alone 
had a moderately inhibitory effect on epidermal G, cells and enhanced the depressing effect 
of the G, inhibitor on epidermal DNA synthesis. The results indicate that the epidermal G. in-
hibitor requires a certain cyclic AMP level in epidermis to be active. Cyclic AMP is probably 
also involved in the regulation of the rate of transit of epidermal G, cells into the S phase but 
the epidermal cyclic AMP level seems not to be so critical for the efficacy of the epidermal G, 
inhibitor. The observations indicate a possible role of the epidermal G, inhibitor in epidermal 
cell differentiation. 
Epidermal cell renewal is evidently regulated 
locally according to a negative feedback principle 
[1,2). The key substance in this closed system is 
probably represented by the chemical messenger 
substance named the epidermal chalone [3), which 
is produced in epidermis and regulates by inhibi· 
tion the rate of cell proliferation of the basal layer 
cells at the same site where it is produced. In rapid, 
regenerative cell proliferation, such as occurs after 
wounding of the skin, epidermal cell renewal is 
most likely regulated mainly by the epidermal 
chalone. In steady-state cell renewal the rate of 
epidermal cell proliferation can, however, be in-
fluenced by other compounds such as hormones 
(for review, see [4)). Thus, Bullough and Laurence 
[5 J found in their early experiments on the epider-
mal chalone that it seemed to be dependent on the 
presence of adrenalin to be active in vitro. More 
recently, Voorhees and co-workers found that cate-
cholamines can mimic some of the effects of 
chalone-containing skin extracts in vitro [6]. These 
observations indicated that cyclic 3',5' -adenosine 
monophosphate (cyclic AMP) and possibly also 
other cyclic nucleotides could be involved in epi-
dermal growth regulation. 
The present study was performed to examine the 
role of cyclic AMP in epidermal growth regulation 
in vivo, and its possible relationship to the epider-
mal chalone. As the skin cannot be manipulated in 
the same manner in vivo as it can in vitro a more 
indirect approach had to used by treating the 
animals with compounds that interfere with the 
cyclic AMP metabolism. 
Recent studies have revealed that chalone-con-
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tammg skin extracts contain at least two sub-
stances that influence epidermal cell proliferation. 
One factor acts mainly on epidermal cells in the 
late part of the G, phase of the cell cycle and is 
found in extracts made from isolated keratinizing 
cells [i ,8 J. The other factor is found in water 
extracts of epidermal basal layer cells and acts 
mainly on epidermal G. cells [9]. Accordingly, the 
present study involved experiments that could 
reveal possible effects of the tested substances on 
epidermal G. and G, cells. 
MATERIALS AND METHODS 
Animals. Hairless mice of both sexes were used in all 
experiments. The animals were 3 to 4 months old and 
they were kept under standardized conditions with fixed 
light and dark periods (artificial light from 6 PM to 6 AM). 
Each cage contained 6 or 8 mice horn on the same day. 
Chemicals. The beta-receptor antagonist propranolol 
was purchased as the commercially available lnderal 
"I.C.I." Thymidine-methyl-'H (sp act 6.7 Ci/mM) was 
obtained from New England I\uclear Corporation. Deme-
colein (Colcemid, Cibs-Geigy AG) in a 0.1% solution and 
caffeine in a 15% stock solution were supplied by the 
hospital pharmacy. 
Preparation of tissue extracts. Water extracts of mouse 
skin were made after homogenization in a mill cooled by 
liquid nitrogen, as described previously [10]. After lyo-
philization the extracts were partially purified by means 
of ethanol precipitation. The lyophilized powder was dis-
solved in phosphate buffer (pH 7.6) and ice-cold ethanol 
was added to a final concentration of 60%. The ~uperna­
tant was dialyzed against distilled water at 0-4°C for 24 
hr and lyophilized. After this procedure, 100 mg of 
lyophilized crude skin powder yields approximately 40 
mg of partially purified skin extract (PSE). Previous 
experiments (unpublished) have shown that PSE made 
in this way has a more repeatable inhibitory effect on 
epidermal cell proliferation than crude lyophilized skin 
extract. 
Assay system. The G,·inhibiting effect of skin extracts 
is evident during the first 3 to 4 hr after intraperitoneal 
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(ip) injection of the lyophilized extract [11]. This inhibi-
tion is best demonstrated after treatment witb Colcemid, 
which arrests epidermal mitoses in the first 4 hr after 
injection of an appropriate dose (0.15 mg per mouse). 
Accordingly, Colcemid was injected ip together with 
PSE, or with propranolol andlor caffeine. The mice were 
killed exactly 4 hr after injection of Colcemid. Colcemid-
arrested mitoses were counted per 8 mm of interfollicular 
epidermis in 5-).1 sections made from the back skin area of 
the mice. 
An ip injection of a chalone-containing skin extract has 
no immediate effect on epidermal DNA synthesis, but 
after a delay of 5 to 6 hr epidermal DNA synthesis is 
reduced for a period of several hours [10]. Accordingly, 
the effect on epidermal DNA synthesis of the agents and 
solutions tested in this study was measured at 12 hr after 
injection. All mice in these experiments received 30 ItCi 
of 'H-thymidine 30 min before they were killed. Sections 
for autoradiography were cut from the back skin of the 
mice, as described previously [8]. The autoradiographs 
were exposed for 4 weeks at 0-4°C and stained with 
hematoxylin. Labeled cells were counted per 8 mm of 
interfollicular epidermis. A cell was considered labeled 
when the grain count over the nucleus was 5 or more. 
In all experiments, half the animals in a cage were 
injected with the extract or compound to be tested, while 
the remaining half served as controls. The mice remained 
in their original cages until killed. The statistical evalua-
tions were made by means of Student's t-test. 
RESULTS 
Various doses of propranolol were tested for their 
effect on the epidermal mitotic rate. Table I shows 
that even a fairly high dose (0.50 mg) did not 
provoke significant alterations in the mitotic rate. 
In the following experiments, however, a lower dose 
was chosen. This dose (0.25 mg) corresponds to 
that used clinicallv, when corrected for the differ-
ence in surface ar~a [12]. This dose of propranolol 
had no effect on the rate of transit of epidermal 
cells from the late G, phase into the S phase (Tab. 
II). Caffeine was also tested in preliminary experi-
ments. Table I shows that ip injection of 0.225 mg 
of caffeine was followed by a significant (p < 0.02) 
inhibition of the epidermal mitotic rate. The same 
dose of caffeine had also a moderately inhibitory 
effect on epidermal DNA synthesis 12 hr after 
injection {Tab. 1Il, but this inhibition was not 
statistically significant (p < 0.10). When corrected 
for differences in surface area \12] such a dose of 
caffeine corresponds to approximately 70-80 mg in 
man. Even after this fairly high dose of caffeine the 
mice did not show signs of altered behavior. 
Caffeine was chosen instead of the more potent 
phosphodiesterase inhibitor, theophylline, which 
in preliminary experiments was locally very irritat-
ing when given ip. When propranolol and caffeine 
were given together the slight inhibitory effect of 
caffeine was no longer significant (Tabs. I, Il). 
In the next series of experiments, mice were 
pretreated with propranolol, caffeine, or with pro-
pranolol and caffeine before they received an ip 
injection of PSE. Propranolol, caffeine, or pro-
pranolol and caffeine, were injected 1 hr before 
administration of PSE. 
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Table III shows that pretreatment with pro-
pranolol alone abolished the mitosis-inhibiting 
effect of PSE. Pretreatment with propranolol and 
caffeine did not alter the usual inhibitory effect of 
PSE on epidermal G, cells. Pretreatment with 
caffeine did not enhance the inhibitory effect of 
PSE on the epidermal mitotic rate. 
Table IV shows that the inhibitory effect ofPSE 
on epidermal DNA synthesis after a delay of 12 hr 
was not altered after pretreatment with pro-
pranolol, or after pretreatment with propranolol 
and caffeine. Preliminary experiments (not pre-
sented here) had shown that a single injection of 
TABLE I. Epidermal mitotic rote after introperitoneal (ip) 
injection of propronolol and caffeine 
Propranolol and caffeine were injected ip together with 
Colcemid (0.15 mg) and the mice killed 4 hr later. 
Colcemid-arrested mitoses were counted in 8 mm of 
interfollicular epidermis from the back skin. The figures 
are given with their S.E. of the mean. N ~ number of 
animals. 
Treatment N Mitoses Depression in percent 
Propranolol. 0.15 mg 8 38.7 ± 3.9 
-
Controls 7 36.1 ± 4.4 
Propranolol, 0.25 mg 4 28.0 ± 2.9 -
Controls 4 30.5 ± 4.7 
Propranolol. 0.50 mg 4 17.2 ± 1.7 -
Controls 4 19.7 ± 1.9 
Caffeine, 0.225 mg 6 31.3 ± 3.5 30 (p < 0.02) 
Controls 6 44.3 ± 3.2 
Propranolol, 0.25 mg. 
and caffeine. 0.225 
mg 6 38.2 ± 3.3 13 (p < 0.20) 
Controls 6 44.6 ± 5.3 
TABLE II. Epidermal DNA synthesis after intraperitoneal 
(ip) injection of propranolol and caffeine 
Propranolol andlor caffeine were injected ip and epi-
dermal DNA synthesis estimated 12 hr later. The mice 
received 30 ItCi of 'H-thymidine 30 min before they were 
killed. Labeled epidermal cells were counted in 8 mm of 
interfollicular epidermis in autoradiographs made from 
the back skin of the mice. The figures are given with their 
S.E. of the mean. N ~ number of animals 
Treatment N Labeling Depression index in percent 
Caffeine, 0.225 mg 6 34.0 ± 7.1 29 (p > 0.10) 
Controls 4 48.8 ± 8.4 
Propranolol, 0.25 mg 6 43.0 ± 2.7 -
Controls 6 40.0 ± 2.8 
Propranolol, 0.25 mg. 
and caffeine. 0.225 
mg 6 41.2 ± 3.0 -
Controls 6 38.2 ± 2.4 
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TABLE m. Epidermal mitotic rate after intraperitoneal 
(ip) injectio~n of partially purified skin extract (PSE) with 
or without pretreatment with propranolol and caffeine 
Propranolol and caffeine were given 1 hr before injec-
tion of partially purified skin extract (PSE) and Colce-
mid (0.15 mg)_ The mice were killed 4 hr after injection of 
Colcemid. Colcemid-arrested mitoses were counted in 8 
mm of interfollicular epidermis from the back skin of the 
mice_ The figures are given with their S.E- of the mean. N 
= number of animals. 
Treatment N Mitoses Depression inpel'cent 
PSE,5mg 8 16_5 ± 1.6 60 (p < 0.01) 
Controls 8 44_6 ± 4.0 
Caffeine, 0_225 mg, 
andPSE,5mg 6 17_0 ± 3_8 59 (p < 0.02) 
Controls 6 41.0 ±S_S 
Propranolol, 0_25 mg, 
andPSE,5 mg 16 24_1 ± 2.3 -
Controls 11 24_8 ± 2.9 
Propranolol, 0.25 mg, 
caffeine, 0.225 mg, 
andPSE,5mg 6 15.8 ± 1.7 65 (p < 0.01) 
Controls 6 44.9 ± 2_2 
TABIE IV_ Epidermal DNA synthesis after intraperitoneal 
(ip) injection of partially purified skin extract (PSE) with 
and without pretreatment with propranolol and/or 
caffeine 
Propranolol and caffeine were given 1 hr before injec-
tion of partially purified skin extract (PSE). Epidermal 
DNA synthesis was estimated at 12 hr after PSE treat-
ment. The mice received 30 "Ci of 'H-thymidine before 
they were killed. The number oflabeled cells was counted 
in 8 mm of interfollicular epidermis in autoradiographs 
made from the back skin of the mice. The figures are 
given with their S.E- of the mean. N = number of 
animals. 
Treatment N Labeling Depression index in percent 
PSE,lOmg 12 20.7 ± 1.8 49 (p < 0.01) 
Controls 14 40-4 ± 2_9 
Caffeine, 0.225 mg, 
and PSE, 10 mg 6 13.0 ± 2_8 I 73 (p < 0.01) 
Controls 6 48.0 ± 3_5 
Propranolol, 0.25 mg, 
and PSE, 10 mg 13 22.5 ± 2.4 45 (p < 0.01) 
Controls 13 41-2 ± 2.1 
Propranolol, 0_25 mg, 
caffeine, 0.225 mg, 
and PSE, 10 mg 6 23.0 ± 3.9 51 (p < 0.01) 
Controls 6 47_2±3.7 
PSE is followed by a 40 to 60% inhibition of 
epidermal DNA synthesis. The small variations in 
epidermal DNA inhibition observed after pretreat-
ment with propranolol, or propranolol and caf-
feine, were well within the usual range. Pretreat-
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ment with caffeine alone, however, enhanced the 
effect of PSE on epidermal G, celis-
DISCUSSION 
The in vitro assay system used by Bullough and 
Laurence [5] to test tissue extracts for mitosis-
inhibiting activity involved the use of adrenalin. 
They also found that adrenalin itself would inhibit 
epidermal mitoses. Later, Voorhees and co-workers 
[6] showed that other catecholamines in addition 
to adrenalin have a similar mitosis-inhibiting ac-
tivity in vitro, and that the catecholamine effect on 
cultured epidermis is mediated by adenyl cyclase. 
Other investigators have demonstrated that epi-
dermis has an adenyl cyclase that can be stimu-
lated by adrenalin and other catecholamines [13. 
14), and a guanyl cyclase that is not stimulated by 
such agents [15]. In vivo. catecholamine-induced 
stimulation of epidermal cyclic AMP is prevented 
by treatment with propranolol [16]. Epidermis also 
contains a protein kinase that is stimulated by 
cyclic AMP [17]. Neither epidermal adenyl cyclase 
nor guanyl cyclase is stimulated by chalone-con-
taining extracts [14,15]. 
The experimental design used by Bullough and 
Laurence [5) and later by Voorhees and co-workers 
[6,18] will only reveal the effect of a certain 
substance on epidermal cells in the G, phase [6J-
The "mitosis-inhibiting" effects mentioned above 
therefore relate only to alterations in the rate with 
which cells pass from the G, phase into mitosis_ 
The conclusion that can be drawn from the investi-
gations referred to above is, accordingly, that both 
water extracts of epidermis and catecholamines 
inhibit epidermal G. cells in a reversible way. 
It is unlikely that catecholamines and specific 
growth-regulating substances such as chalones act 
in exactly the same way on susceptible epidermal 
cells. Thus, skin extracts inhibit epidermal G. cells 
even in adrenalectomized animals [18J. Some im-
portant differences between the chalone and cate-
cholamine effects on epidermal G, cells are also 
evident from the present study. Catecholamines 
act on the cell surface and their effect is coun-
teracted by beta-receptor antagonists [14]. Our 
findings revealed that the G, inhibitor present in 
PSE was inactive after pretreatment with pro-
pranolol but that it had usual inhibitory effects on 
epidermal G, cells when the animals were pre-
treated with propranolol and caffeine. After pre-
treatment with both a beta-receptor antagonist 
(propranolol) and a phosphodiesterase inhibitor 
(caffeine) the beta-receptor sites on the cell surface 
are blocked, but the cyclic AMP already present in 
the cells is more stable as its breakdown by 
phosphodiesterase is prevented by caffeine. Thus, 
the epidermal G. inhibitor seems not to act on the 
cell surface, at least not on the beta-receptor sites, 
but it is dependent on a certain concentration of 
cyclic AMP in the cells to be active. Increasing 
epidermal cyclic AMP levels above a certain value 
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did not result in any further reduction in the 
mitotic rate. 
These findings could account for the "adrenalin 
wash" effect observed by Bullough and Laurence 
[5] and later by Marrs and Voorhees [18]. A brief 
exposure of the pieces of skin to adrenalin is 
followed by an increase in epidermal adenyl cy-
clase activity [13,14]. Such a reestablishment of a 
critical epidermal cyclic AMP level would again 
make the cells susceptible to the epidermal G, 
inhibitor (for further discussion of this, see [6]). 
The G, inhibitor present in PSE reduced epider-
mal DNA synthesis after the usual delay even after 
pretreatment with propranolol. It is therefore rea-
sonable to assume that the G, inhibitor is not as 
dependent on epidermal cyclic AMP levels as the 
G. inhibitor. On the other hand, caffeine evidently 
enhanced the degree of inhibition of epidermal 
DNA synthesis. This is in accordance with reports 
that have demonstrated that cyclic AMP and its 
derivatives are in some way involved in the regula-
tion of the rate of transit of epidermal G, cells into 
the S phase [20-22]. 
The role of the G, inhibitor in epidermal growth 
regulation seems to be easily explained. It is found 
in keratinizing cells [8] and regulates by inhibition 
the rate with which cells pass from the G, phase 
into the S phase [10]. The role of the G, inhibitor is 
not so clear. This factor can be extracted from 
epidermal basal layer cells [9], is present in dermis 
[23], and it acts on cells in the middle part of the 
G. phase [11]. There is evidence that at least some 
cell types are programmed for their G, activities 
while the cells are in the G. phase [24]. Other 
experiments have revealed that some cell types 
have to pass through a final mitosis before they can 
start differentiation [25]. On the basis of these 
findings it is tempting to speculate that the epider-
mal G, inhibitor could be of importance for epider-
mal cell differentiation. Any agent that has the 
ability to alter the programming of a certain cell 
population would have profound effects on the 
long-term rate of cell proliferation. In epidermis, it 
is assumed that a mitosis results in two identical 
daughter cells [26]. At present this is still a theory 
and it is quite possible that the daughter cells are 
not identically programmed in all respects. 
In several tissues and cells, cyclic AMP seems to 
be involved in processes related to cell differentia-
tion. The relationship between the epidermal G, 
inhibitor and epidermal cyclic AMP could there-
fore lend support to the hypothesis that the G, 
inhibitor is involved in cell differentiation, and 
that it inhibits epidermal G. cells only as a 
secondary phenomenon. 
The present study has shown that the epidermal 
G, inhibitor depresses epidermal DNA synthesis 
even after pretreatment with a beta-receptor an-
tagonist but that its effect is enhanced by pretreat-
ment with caffeine. Its regulatory effect on epider-
mal cell renewal is probably related to, but not 
critically dependent on, epidermal cyclic AMP 
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levels. The epidermal G. inhibitor, on the other 
hand, appears to require a certain epidermal cyclic 
AMP level to be active. Its close relationship to the 
adenyl cyclase system could indicate that this 
factor is involved in epidermal differentiation. 
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